

Gold-RX.com - Generic drugs
|
News: International
Category:
Business
Region:
International
|
|
PHARMACY CRIES FOUL AS ELECTRONIC DATA SYSTEMS DETAILS ITS THREE MONTH MEDI-CAL BACK PAYMENT TIMELINE FOR PHARMACY MEDI-CAL PROVIDERS
Source: MarketWatch
Date: 16-Jul-2008
The California Pharmacists Association cries foul against Electronic Data Systems' (EDS) re-payment timeline for Medi-Cal pharmacy providers. Last Friday, pharmacy providers were notified that a three-judge panel of the Ninth Circuit Court of Appeals acted to halt the ten percent payment cuts for prescription drugs dispensed under the Medi-Cal Program. While this was a victory for pharmacy and the patients they serve, EDS, which processes Medi-Cal claims, sent out a memo on Tuesday, July 15, 2008, which was then posted on the Department of Health Care Services (DHCS) web site, detailing their plan to handle the Medi-Cal repayment process to make pharmacy whole on transactions that took place from July 11, 2008 and beyond.
Full text
|
|
Category:
Law suits
Region:
International
|
|
GENERIC DRUG GROUP SPENT $434,495 LOBBYING IN 1Q
Source: CNNMoney.com
Date: 30-Jun-2008
The Generic Pharmaceutical Association spent $434,495 lobbying in the first quarter on issues affecting the drug industry, according to a recent disclosure report.
Full text
|
|
Category:
Drugs Prices
Region:
International
|
|
GIANT FOOD INTROS $9.99 GENERIC DRUG PLAN
Source: Consumer Affairs
Date: 23-Jun-2008
Author: Truman Lewis
Giant Food is the latest supermarket chain to announce a $9.99 discount program for generic drugs.
Full text
|
|
Category:
Business
Region:
International
|
|
MYLAN TAKES GENERIC AIM AT TEVA
Source: Motley Fool
Date: 11-Jun-2008
Author: Brian Orelli
Teva Pharmaceutical (Nasdaq: TEVA) is getting a taste of its own medicine. The generic-drug maker, which also makes branded drugs, including multiple sclerosis drug Copaxone, has some generic competition headed its way.
Full text
|
|
Category:
Law suits
Region:
International
|
|
FDA PANEL BACKS GLAXO PLATELET DRUG PROMACTA
Source: Wall Street Journal
Date: 30-May-2008
Author: Peter Loftus
An outside advisory panel recommended Friday that the Food and Drug Administration approve a proposed GlaxoSmithKline PLC drug to treat a blood condition.
Full text
|
|
|
Next page >>
|
|

- Dear Support,
Received the order today. Fast shipping, good packaging, and everything looks great. Many thanks for the excellent service.
- Mike S.,
Glendale, United States
|